ArticlePediatric research2026
Pro-inflammatory and matricellular protein expression patterns associated with bronchopulmonary dysplasia severity.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary inflammation and dysregulated repair have been linked to the development of bronchopulmonary dysplasia (BPD), but disease severity varies widely, and the mechanisms leading to BPD heterogeneity remain unclear. We hypothesized that levels of pro-inflammatory and matricellular proteins in preterm infants airways in the first week of life are associated with BPD severity.
methodsWe collected tracheal aspirates from preterm infants, born ≤32 weeks gestational age, receiving mechanical ventilation in the first week of life. Protein levels were measured in the supernatants. BPD severity categories were defined by the Jensen classification.
resultsWe observed three distinct expression patterns, including (i) proteins increased in any BPD severity, most significantly pro-inflammatory interleukin (IL)-17A and IL-23, (ii) proteins elevated only in grade 1 BPD (IL-12 isoforms, the matricellular protein periostin), and (iii) proteins decreased in grade 2/3 BPD, notably the matricellular protein thrombospondin 1 (THBS1). Low THBS1 discriminated grade 2/3 BPD, whereas high periostin levels discriminated grade 1 BPD, adjusting for sex and birth weight.
conclusionsTracheal aspirate levels of select pro-inflammatory and matricellular proteins show distinct patterns associated with BPD severity categories. THBS1 and periostin, tissue repair, immune, and angiogenesis regulators, display differential expression and potential roles as biomarkers and therapeutic targets in the pathogenesis of BPD severity categories. IMPACT: We identify differential patterns and relationships between pro-inflammatory cytokine and matricellular protein expression levels in preterm infant airways by bronchopulmonary dysplasia (BPD) severity. Particularly, low levels of the matricellular protein thrombospondin 1 discriminated grade 2/3 BPD from grade 1 and 0, whereas high levels of the matricellular protein periostin discriminated grade 1 BPD, all after adjusting for sex and birth weight. Quantifying pro-inflammatory and tissue repair signals in preterm infant airways provides novel insights into early mechanisms that may impact BPD severity. Early biomarkers of BPD severity can provide crucial information for diagnosis, prognosis, and potential future treatment selection.
Identifiers
42860440What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.